Literature DB >> 21460608

Romiplostim reverts the thrombocytopenia in dengue hemorrhagic fever.

S M Rodríguez-Mejorada, C G Rosel-Gómez, R A Rosado-Castro, M A Domingo-Padilla, G J Ruiz-Delgado.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21460608     DOI： 10.1016/s1658-3876(11)50062-7

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


× No keyword cloud information.
  2 in total

1.  Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial.

Authors:  Sajib Chakraborty; Saruar Alam; Mohammad Sayem; Mousumi Sanyal; Tonmoy Das; Piyal Saha; Mohammad Sayem; Bartholomia Keya Byapari; Chowdhury Tamanna Tabassum; Ahmedul Kabir; Md Robed Amin; A H M Nurun Nabi
Journal:  EClinicalMedicine       Date:  2020-11-21

Review 2.  Thrombopoietin Receptor Agonists: Can These Be the Future Answer to the Deadly Thrombocytopenia in Dengue Fever?

Authors:  Sayak Roy
Journal:  Cureus       Date:  2019-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.